Development of an In Vitro Assessment Method for Chemotherapy-Induced Peripheral Neuropathy (CIPN) by Integrating a Microphysiological System (MPS) with Morphological Deep Learning of Soma and Axonal Images
Several anticancer drugs used in cancer therapy induce chemotherapy-induced peripheral neuropathy (CIPN), leading to dose reduction or therapy cessation. Consequently, there is a demand for an in vitro assessment method to predict CIPN and mechanisms of action (MoA) in drug candidate compounds. In t...
Main Authors: | Kazuki Matsuda, Xiaobo Han, Naoki Matsuda, Makoto Yamanaka, Ikuro Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Toxics |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6304/11/10/848 |
Similar Items
-
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
by: Rozalyn L. Rodwin, et al.
Published: (2022-03-01) -
Lentinula edodes mycelia extract abrogates chemotherapy-evoked cold and mechanical allodynia in mice
by: Masanobu Tsubaki, et al.
Published: (2025-02-01) -
Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine
by: David Balayssac, et al.
Published: (2023-12-01) -
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
by: Hana Starobova, et al.
Published: (2017-05-01) -
Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy
by: Kevin M. Huang, et al.
Published: (2021-01-01)